Prostaglandin inhibitors and calcium channel blockers were ranked as the top tocolytic therapy options in terms of outcomes of 48-hour delay in delivery, neonatal mortality, respiratory distress syndrome, and maternal side effects, according to a systematic review and network meta-analysis published Oct. 9 in BMJ.
Pharmacists Should Take a Proactive Approach When Addressing Controlled Substance Concerns
March 24th 2024At this year’s American Pharmacists Association Annual Meeting & Exposition, Mark Garofoli urged pharmacists to develop strong documentation practices and go beyond baseline federal regulations to care for patients with red flags.